Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the company. StockNews.com cut Sientra from a "hold" rating to a "sell" rating in a report on Tuesday, May 10th. Lake Street Capital assumed coverage on Sientra in a report on Thursday, April 14th. They set a "buy" rating and a $8.00 price objective on the stock. Maxim Group reiterated a "buy" rating and set a $5.00 price objective on shares of Sientra in a report on Friday, May 13th. Finally, Canaccord Genuity Group cut their price objective on Sientra from $8.00 to $5.00 in a report on Friday, May 13th. One analyst has rated the stock with a sell rating and six have issued a buy rating to the company. According to data from MarketBeat, Sientra currently has a consensus rating of "Moderate Buy" and an average price target of $7.29.
Sientra Stock Up 31.1 %
NASDAQ:SIEN traded up $0.33 during trading on Friday, hitting $1.39. The stock had a trading volume of 1,219,767 shares, compared to its average volume of 372,037. The company has a market capitalization of $87.07 million, a PE ratio of -1.40 and a beta of 1.94. The company's 50-day moving average price is $0.93 and its two-hundred day moving average price is $1.74. The company has a debt-to-equity ratio of 2.61, a quick ratio of 0.95 and a current ratio of 1.59. Sientra has a 12 month low of $0.70 and a 12 month high of $7.87.
Sientra (NASDAQ:SIEN - Get Rating) last released its earnings results on Thursday, May 12th. The medical instruments supplier reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.03). Sientra had a negative net margin of 71.61% and a negative return on equity of 498.54%. The firm had revenue of $21.40 million during the quarter, compared to the consensus estimate of $20.25 million. As a group, sell-side analysts forecast that Sientra will post -0.93 EPS for the current year.